Spejlstale Indtastning: En ny teknik til stemmepersonlig taleindtastning til ikke -flydende afasi (MSE)
The goal of this clinical trial is to test the use of voice personalization through artificial intelligence (AI) voice cloning on speech entrainment tasks to improve language production of persons with aphasia (PWA). The main question the study aims to answer is:
- What is the impact of personalized voice on speech entrainment in PWA compared to traditional speech entrainment?
Speech entrainment is a technique used by speech-language pathologists to improve the speech production of PWA. Traditionally, speech therapists act as the model for participants to speak along with to improve their speech production. This study proposes the use of one's own voice (digitally altered) to improve speech production.
The study uses a mobile health approach to administer speech entrainment treatment through a mobile app.
- Smartphones with the mobile app pre-installed will be mailed to participants at no cost.
- Participants will complete treatment in the comfort of their homes.
- The experimental treatments involve: mirror speech entrainment (speaking along to one's own voice) and traditional speech entrainment (speaking along to someone else's voice).
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Florida
-
Tampa, Florida, Forenede Stater, 33612
- University of South Florida
-
Tampa, Florida, Forenede Stater, 33614
- University of South Florida
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Adults between the ages of 18-70 years old
- Dominant English-speaking
- Aphasia due to left hemisphere stroke
Exclusion Criteria:
- Individuals with aphasia due to other causes such as dementia, Alzheimer's disease and Parkinsonism
- Non-dominant English adult speakers
- Persons with significant difficulties with language comprehension
- Persons with concomitant cognitive disability
- Persons with uncorrected sensory deficits.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Experiment 1: Feasibility Study
Participants will receive two treatments sequentially: mirror speech entrainment using the auditory-only modality followed by mirror speech entrainment using the auditory-visual modality. |
Speech entrainment with the user's own voice using auditory-only and auditory-visual modalities. |
|
Eksperimentel: Experiment 2: Mirror SE versus Traditional SE (Auditory-only)
This arm investigates the use of mirror speech entrainment using auditory only feedback and traditional speech entrainment using auditory only feedback. |
Speech entrainment with the user's own voice using auditory-only and auditory-visual modalities. Traditional speech entrainment (speech entrainment using an external agent's voice) using the auditory-only modality (users only listen and speak along to auditory stimuli) |
|
Eksperimentel: Experiment 3: Mirror SE versus Traditional SE (Auditory-visual)
This arm will investigate the effect of mirror speech entrainment in the auditory-visual modality versus traditional speech entrainment in the auditory-visual modality. |
Speech entrainment with the user's own voice using auditory-only and auditory-visual modalities. Traditional speech entrainment (speech entrainment using an external agent's voice) using the auditory-visual modality (users listen and speak along to both auditory and visual stimuli (mouth movements) |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Speaking rate
Tidsramme: From enrollment to the end of treatment at 6 weeks
|
Language production as assessed by number of correct words produced per minute |
From enrollment to the end of treatment at 6 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Neurologiske manifestationer
- Cerebrovaskulære lidelser
- Hjernesygdomme
- Sygdomme i centralnervesystemet
- Sygdomme i nervesystemet
- Karsygdomme
- Hjerte-kar-sygdomme
- Neuroadfærdsmæssige manifestationer
- Kommunikationsforstyrrelser
- Sprogforstyrrelser
- Taleforstyrrelser
- Patologiske tilstande, tegn og symptomer
- Tegn og symptomer
- Slag
- Afasi
- Afasi, Broca
Andre undersøgelses-id-numre
- 007481
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Individual participant data will only be shared with approved members of the research team.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .